IBCL-249 Mosunetuzumab Monotherapy Is an Effective and Well-Tolerated Treatment Option for Patients With Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Who Have Received ≥2 Prior Lines of Therapy: Pivotal Results From a Phase I/II Study

1. Budde, E.L.
2. Sehn, L.H.
3. Matasar, M.
4. Schuster, S.J.
5. Assouline, S.
6. Giri, P.
7. Kuruvilla, J.
8. Canales, M.
9. Dietrich, S.
10. Fay, K.
11. Ku, M.
12. Nastoupil, L.
13. Wei, M.C.
14. Yin, S.
15. Doral, M.Y.
16. Li, C.-C.
17. Huang, H.
18. Negricea, R.
19. Penuel, E.
20. O'Hear, C.
21. Bartlett, N.L.